News

Granules India climbs after USFDA approval for type 2 diabetes drug

Publication: Business Standard Published: 2 weeks ago

Granules India gained 2.21% to Rs 369.50 after the company said it received US drug regulator's approval of metformin hydrochloride ER tablets USP, 500 mg and 1000 mg.

Read full post